# Toshiyuki Mori

> Toshiyuki Mori is a Series B investor at Newton Biocapital backing Medical and Biotechnology. See 1 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Newton Biocapital](https://shizune.co/investors/profile/newton-biocapital)
- Location: Tokyo, Japan
- Total investments: 1
- Last investment: Mar 2019
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/toshiyuki-mori-b7a3ab8/?ppe=1

Toshiyuki Mori is a Series B investor at Newton Biocapital in Tokyo focused on Medical and Biotechnology. Dr. Toshiyuki Mori, also known as Toshi, Ph.D. serves as Chief Scientific Officer at Whiz Partners Inc. Dr. Mori served as Senior Director of Technology & Alliance Management at Takeda San Francisco, Inc. Dr. Mori's responsibilities encompass the leadership all aspects of Technology Management to support the initiatives of the center ofexcellence, including identification and assessment of third party technologies, antibody product candidates and antibody targets.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 1 | 100% |
| Biotechnology | 1 | 100% |
| Nursing and Residential Care | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| EditForce | EditForce develops drugs and seeds by using nucleic acid (DNA/RNA) manipulation technologies. | $123.3M | Series B | Mar 01, 2019 |  |

1 of 1 investments shown.

## Co-investors
- [ITOCHU Technology Ventures](https://shizune.co/investors/profile/itochu-technology-ventures) — VC Fund, 1 deal together
- [Japan Science and Technology Agency](https://shizune.co/investors/profile/japan-science-and-technology-agency) — VC Fund, 1 deal together
- [K4 Ventures](https://shizune.co/investors/profile/k4-ventures-8a86) — VC Fund, 1 deal together
- [QB Capital](https://shizune.co/investors/profile/qb-capital) — VC Fund, 1 deal together
- [UTEC - The University of Tokyo Edge Capital Partners](https://shizune.co/investors/profile/utec) — VC Fund, 1 deal together

## About Newton Biocapital

VC Fund · Brussels, Belgium

Newton Biocapital is a Venture Capital Fund incorporated in Belgium, focused on financing biotech and life science projects in the "core of Europe" (B, NL, D, F) and Japan for the prevention and treatment of chronic diseases.Their approach as lead investor is to support promising start-up projects as well as neglected or undervaluedlate-stage projects, in order to mitigate the risks and to create investor value. The leadership team consi.sts of specialists with long-standing management and investor experience who coach bio-entrepreneurs through the development stages of their projects.

4 contacts available at Newton Biocapital.

| Name | Title | Profile |
| --- | --- | --- |
| Els Hubloux | Partner | https://shizune.co/investors/profile/els-hubloux |
| Goro Takeda | Managing Partner | https://shizune.co/investors/profile/goro-takeda |
| Toshiyuki Mori | Partner, Tokyo | https://shizune.co/investors/profile/toshiyuki-mori |
| Alain Parthoens | Managing Partner and Founder | https://shizune.co/investors/profile/alain-parthoens |

## Similar investors

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does Toshiyuki Mori invest in?

Toshiyuki Mori invests primarily in Medical, Biotechnology and Nursing and Residential Care startups, most often at Series B stage. Most of the 1 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Toshiyuki Mori last invest?

The most recent investment recorded for Toshiyuki Mori closed in Mar 2019. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co